Compound for the treatment of enteroviruses
AssigneeBiota Scientific Management Pty Ltd.
InventorsJohan Neyts, Armando De Palma, Hendrik Jan Thibaut, Pieter Leyssen, Simon Tucker
Life of this patent
Estimating the term…
Abstract
The present invention relates to the treatment, alleviation, prevention or reduction in the incidence of symptoms, diseases or conditions resulting from or associated with enteroviruses, more particularly the enteroviral infections they cause.
Claims7
A method for treating, alleviating, or reducing an enteroviral infection caused by a serotype of poliovirus 1 (PV1) or enterovirus 71 (EV71) comprising administering 3-ethoxy-6-{2-[1-(6-methyl-pyridazin-3-yl)-piperidin-4-yl]-ethoxy}-benzo[d]isoxazole or a pharmaceutically acceptable salt thereof to a subject suffering from said infection, and further comprising administering a second anti-enteroviral agent, wherein the second anti-enteroviral agent is rupintrivir or enviroxime.
Dependencies are inferred from the claim text.